Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 6912 matches for

EnzBond, a new biotechnology company from Oxford University, has been formed to commercialise in-silico technology, which makes utilising enzymes in drug manufacturing both cost-effective and time-efficient.

What can I do if I'm not eligible to apply?

Pre-clinical Medicine - Entry requirements Pre-clinical Medicine - General queries

What are examples of bullying and harassment?

What can I do if an incident occurs?

When should I report an incident?

Where can I find support?

What is the Medical School's policy on bullying and harassment?

Graduate Entry Medicine: Do you provide a template/guidance for referees?

Graduate Entry Medicine: Can I apply with Access to HE/Foundation qualifications rather than A-levels?

Graduate Entry Medicine: Do I need work or volunteering experience?

Pre-clinical medicine: Will my Further Maths Level 2 or Level 3 qualification count towards the GCSE count?

Pre-clinical Medicine - BMAT, GCSEs and short-listing

Biomedical Sciences: My other applications will be for Medicine. Will I be considered?

How do I join a Trade Union?

Pre-clinical medicine: Does Medicine participate in the Organ Scholarship scheme?

Pre-clinical Medicine - General queries

How can I get a copy of my degree certificate or an academic transcript?

When is my reunion?

I want to contribute an article to Oxford Medicine - the OMA newsletter. How do I do this?

What is Oxford Alumni Online? How do I register?

Can you help me trace an ancestor who studied medicine at Oxford?

I want to get in touch with a colleague from medical school. How do I do this?

I want to study medicine at Oxford. Can you help me?

Clinical Medicine Electives - Medicine Graduate Entry Medicine Pre-clinical Medicine - General queries

Load More

Similar stories

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer

Awards and Appointments General Innovation Research

Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.

Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal

Awards and Appointments Coronavirus COVID-19 General Innovation Research

Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

General Innovation

The University of Oxford announced today that it has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

BioEscalator’s Enara Bio partners with Boehringer Ingelheim to develop novel cancer immunotherapies

General Innovation

Enara Bio, a start-up located in the University’s BioEsclator, has announced a strategic collaboration and licensing agreement with Boehringer Ingelheim, worth over €876M (£787M), to lead the discovery and validation of Dark Antigens to target lung and gastrointestinal cancers.